Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Apr 2022. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 5034021018 | Ceftriaxone (as ceftriaxone sodium) 1 g and tazobactam (as tazobactam sodium) 125 mg powder for solution for injection vial | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 5034022013 | Product containing precisely ceftriaxone (as ceftriaxone sodium) 1 gram and tazobactam (as tazobactam sodium) 125 milligram/1 vial powder for conventional release solution for injection (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Ceftriaxone (as ceftriaxone sodium) 1 g and tazobactam (as tazobactam sodium) 125 mg powder for solution for injection vial | Is a | Ceftriaxone and tazobactam only product in parenteral dose form | true | Inferred relationship | Some | ||
| Ceftriaxone (as ceftriaxone sodium) 1 g and tazobactam (as tazobactam sodium) 125 mg powder for solution for injection vial | Has manufactured dose form | Powder for solution for injection | true | Inferred relationship | Some | ||
| Ceftriaxone (as ceftriaxone sodium) 1 g and tazobactam (as tazobactam sodium) 125 mg powder for solution for injection vial | Has unit of presentation | Vial (unit of presentation) | true | Inferred relationship | Some | ||
| Ceftriaxone (as ceftriaxone sodium) 1 g and tazobactam (as tazobactam sodium) 125 mg powder for solution for injection vial | Plays role | Antibacterial therapeutic role (role) | true | Inferred relationship | Some | ||
| Ceftriaxone (as ceftriaxone sodium) 1 g and tazobactam (as tazobactam sodium) 125 mg powder for solution for injection vial | Has precise active ingredient | Ceftriaxone sodium | true | Inferred relationship | Some | 1 | |
| Ceftriaxone (as ceftriaxone sodium) 1 g and tazobactam (as tazobactam sodium) 125 mg powder for solution for injection vial | Has basis of strength substance (attribute) | Ceftriaxone (substance) | true | Inferred relationship | Some | 1 | |
| Ceftriaxone (as ceftriaxone sodium) 1 g and tazobactam (as tazobactam sodium) 125 mg powder for solution for injection vial | Has presentation strength numerator unit | g | true | Inferred relationship | Some | 1 | |
| Ceftriaxone (as ceftriaxone sodium) 1 g and tazobactam (as tazobactam sodium) 125 mg powder for solution for injection vial | Has presentation strength denominator unit (attribute) | Vial (unit of presentation) | true | Inferred relationship | Some | 1 | |
| Ceftriaxone (as ceftriaxone sodium) 1 g and tazobactam (as tazobactam sodium) 125 mg powder for solution for injection vial | Has precise active ingredient | Tazobactam sodium (substance) | true | Inferred relationship | Some | 2 | |
| Ceftriaxone (as ceftriaxone sodium) 1 g and tazobactam (as tazobactam sodium) 125 mg powder for solution for injection vial | Has basis of strength substance (attribute) | Tazobactam | true | Inferred relationship | Some | 2 | |
| Ceftriaxone (as ceftriaxone sodium) 1 g and tazobactam (as tazobactam sodium) 125 mg powder for solution for injection vial | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 2 | |
| Ceftriaxone (as ceftriaxone sodium) 1 g and tazobactam (as tazobactam sodium) 125 mg powder for solution for injection vial | Has presentation strength denominator unit (attribute) | Vial (unit of presentation) | true | Inferred relationship | Some | 2 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR